Thomas O. Daniel

2015

In 2015, Thomas O. Daniel earned a total compensation of $7.3M as Chairman, Celgene Research at Celgene, a 4% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$3,075,016
Option Awards$1,405,470
Salary$717,500
Stock Awards$1,969,451
Other$174,541
Total$7,341,978

Daniel received $3.1M in non-equity incentive plan, accounting for 42% of the total pay in 2015.

Daniel also received $1.4M in option awards, $717.5K in salary, $2M in stock awards and $174.5K in other compensation.

Rankings

In 2015, Thomas O. Daniel's compensation ranked 905th out of 13,638 executives tracked by ExecPay. In other words, Daniel earned more than 93.4% of executives.

ClassificationRankingPercentile
All
905
out of 13,638
93rd
Division
Manufacturing
312
out of 5,190
94th
Major group
Chemicals And Allied Products
114
out of 1,854
94th
Industry group
Drugs
88
out of 1,528
94th
Industry
Pharmaceutical Preparations
72
out of 1,182
94th
Source: SEC filing on April 28, 2016.

Daniel's colleagues

We found five more compensation records of executives who worked with Thomas O. Daniel at Celgene in 2015.

2015

Robert Hugin

Celgene

Chief Executive Officer

2015

Jacqualyn Fouse

Celgene

President Hematology and Oncology

2015

Mark Alles

Celgene

Chief Operating Officer

2015

Peter Kellogg

Celgene

Chief Financial Officer

2015

Scott Smith

Celgene

President, Immunology & Inflammation

You may also like